Retroperitoneoscopic access in organ-preserving treatment of renal cell carcinoma
نویسندگان
چکیده
Background . Renal cell carcinoma is one of the most common urologic cancers. Due to development modern diagnostic methods, kidney tumors are often diagnosed at early stages (cT1a-T1b). The golden standard treatment localized renal tumor resection. In retroperitoneoscopic access, time artery access decreased, risk intra- and postoperative complications reduced. Retroperitoneal preferable for located on lateral or posterior surface. Aim To analyze results patients after Materials methods Between 2018 2021, A.F. Tsyb Medical Radiological Research Center - branch National 47 resections were performed (29 (61.7 %) in men, 18 (38.3 women) due stage cT1aN0M0 carcinoma. Retrospective analysis demographic data, comorbid status, characteristics, operative time, blood loss volume, frequency severity per Clavien-Dindo classification was performed. Complexity resection evaluated using R.E.N.A.L. scale. Results Mean patient age 63 (38-79) years, body mass index 29.9 (22-39) kg/m 2 Tumor left 24 (51.0 cases, right 22 (46.8 bilateral lesions 1 (2.2 case. size 22.4 (11-39) mm. Resection had low complexity 35 (74.5 intermediate 12 (25.5 cases. 156 (80-280) minutes, mean warm ischemia 19 (7-32) number with zero 15 (31.9 %), volume 53 (10-300) mL, without parenchyma suturing 10 (21.3 %). hospitalization surgery 5 days. Postoperative observed 4 (8.5 cases: bleeding (severity grade II classification) (2.1 case, infectious II) (4.2 subcutaneous hematoma I) Conclusion Retroperitoneoscopic effective safe. This confirmed by complications. allows reduce pain management medication which accelerates mobilization recovery. Comparative shows that has same effectiveness as laparoscopic
منابع مشابه
Prognostic value of p53 in renal cell carcinoma
Background and Objectives: RCC is one of the most common genitourinary cancers. Accurate prediction of prognosis would be valuable for adjuvant trial design, counseling and effectively scheduling follow up visits. P53 is a tumor suppressor gene that expresses a protein that involved in both cell-cycle ar...
متن کاملSurvival after organ preserving treatment for T4a laryngeal squamous cell carcinoma.
We read with interest the study published by Knab et al. [1] that had brought to our attention the need to further investigate the convention that patients with large volume T4 (LVT4) laryngeal tumors (LTs) should be treated with upfront laryngectomy. LVT4 LTs are defined as tumor extension >1 cm into the base of the tongue or extension of the tumor through the thyroid cartilage [2]. Randomized...
متن کاملDyspnea as the First Manifestation of Silent Renal Cell Carcinoma
Renal cell carcinoma (RCC) accounts for only 3% of adult malignancies, and the lung is the most common site of metastasis of this tumor, which may be accompanied by pleural metastasis. However, solitary pleural involvement is very rare and its presentation with dyspnea as the first manifestation of RCC is extremely rare.We describe a 39-year-old male with episodes of dyspnea dating back 6...
متن کاملBilateral Synchronous Sporadic Renal Cell Carcinoma: Retroperitoneoscopic Strategies and Intermediate Outcomes of 60 Patients
OBJECTIVE To evaluate the presentation, management, pathology, and functional and oncological outcomes of patients undergoing retroperitoneoscopic treatment of bilateral synchronous sporadic RCC at our institution. METHODS We retrospectively evaluated the records of 60 patients with bilateral synchronous sporadic RCC who underwent retroperitoneoscopic treatment at the General Hospital of Peop...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Onkourologiâ
سال: 2023
ISSN: ['1996-1812', '1726-9776']
DOI: https://doi.org/10.17650/1726-9776-2023-19-1-25-34